Indaptus Therapeutics, Inc. (INDP)
Nasdaq: INDP · CIK 0001857044 · United States
Every official Indaptus Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open INDP filings
Indaptus Therapeutics, Inc. documents
- Indaptus Therapeutics, Inc. 10-K 2026INDP 10-K 2026: annual report for fiscal 2026
- Indaptus Therapeutics, Inc. 10-K 2025INDP 10-K 2025: annual report for fiscal 2025
- Indaptus Therapeutics, Inc. 10-K 2024INDP 10-K 2024: annual report for fiscal 2024
- Indaptus Therapeutics, Inc. 10-K 2023INDP 10-K 2023: annual report for fiscal 2023
- Indaptus Therapeutics, Inc. 10-K 2022INDP 10-K 2022: annual report for fiscal 2022
- Indaptus Therapeutics, Inc. 10-Q 2026INDP 10-Q 2026: quarterly report for fiscal 2026
- Indaptus Therapeutics, Inc. 10-Q 2025INDP 10-Q 2025: quarterly report for fiscal 2025
- Indaptus Therapeutics, Inc. 10-Q 2024INDP 10-Q 2024: quarterly report for fiscal 2024
- Indaptus Therapeutics, Inc. 10-Q 2023INDP 10-Q 2023: quarterly report for fiscal 2023
- Indaptus Therapeutics, Inc. 10-Q 2022INDP 10-Q 2022: quarterly report for fiscal 2022
- Indaptus Therapeutics, Inc. 8-K 2026INDP 8-K 2026: current report for fiscal 2026
- Indaptus Therapeutics, Inc. 8-K 2025INDP 8-K 2025: current report for fiscal 2025
- Indaptus Therapeutics, Inc. 8-K 2024INDP 8-K 2024: current report for fiscal 2024
- Indaptus Therapeutics, Inc. 8-K 2023INDP 8-K 2023: current report for fiscal 2023
- Indaptus Therapeutics, Inc. 8-K 2022INDP 8-K 2022: current report for fiscal 2022
- Indaptus Therapeutics, Inc. DEF 14A 2026INDP DEF 14A 2026: proxy statement for fiscal 2026
- Indaptus Therapeutics, Inc. DEF 14A 2025INDP DEF 14A 2025: proxy statement for fiscal 2025
- Indaptus Therapeutics, Inc. DEF 14A 2024INDP DEF 14A 2024: proxy statement for fiscal 2024
- Indaptus Therapeutics, Inc. DEF 14A 2023INDP DEF 14A 2023: proxy statement for fiscal 2023
- Indaptus Therapeutics, Inc. DEF 14A 2022INDP DEF 14A 2022: proxy statement for fiscal 2022
- Indaptus Therapeutics, Inc. Form 4 2026INDP Form 4 2026: insider trading filing for fiscal 2026
- Indaptus Therapeutics, Inc. Form 4 2025INDP Form 4 2025: insider trading filing for fiscal 2025
- Indaptus Therapeutics, Inc. Form 4 2024INDP Form 4 2024: insider trading filing for fiscal 2024
- Indaptus Therapeutics, Inc. Form 4 2023INDP Form 4 2023: insider trading filing for fiscal 2023
- Indaptus Therapeutics, Inc. Form 4 2022INDP Form 4 2022: insider trading filing for fiscal 2022
- Indaptus Therapeutics, Inc. S-1 2026INDP S-1 2026: registration statement for fiscal 2026
- Indaptus Therapeutics, Inc. S-1 2025INDP S-1 2025: registration statement for fiscal 2025
- Indaptus Therapeutics, Inc. S-1 2024INDP S-1 2024: registration statement for fiscal 2024
- Indaptus Therapeutics, Inc. S-1 2023INDP S-1 2023: registration statement for fiscal 2023
- Indaptus Therapeutics, Inc. S-1 2022INDP S-1 2022: registration statement for fiscal 2022
- Indaptus Therapeutics, Inc. 13F 2026INDP 13F 2026: institutional holdings for fiscal 2026
- Indaptus Therapeutics, Inc. 13F 2025INDP 13F 2025: institutional holdings for fiscal 2025
- Indaptus Therapeutics, Inc. 13F 2024INDP 13F 2024: institutional holdings for fiscal 2024
- Indaptus Therapeutics, Inc. 13F 2023INDP 13F 2023: institutional holdings for fiscal 2023
- Indaptus Therapeutics, Inc. 13F 2022INDP 13F 2022: institutional holdings for fiscal 2022
More companies